37 - A MULTI-CENTER, NON-INFERIORITY STUDY TO EVALUATE THE EFFICACY OF ELIMINATION OF HIGH-DOSE ASPIRIN IN THE ACUTE STAGE OF KAWASAKI DISEASE FOR PREVENTING CORONARY ARTERY LESIONS (KIAA TRIAL)
59 - EVALUATING THE EFFICACY OF ESTABLISHED SCORES IN PREDICTING IVIG RESISTANCE IN INFANT KAWASAKI DISEASE
Location: Outremont
Author: Young Tae Lim, n/a – Department of Pediatrics, Kyungpook National University School of Medicine Hospital
Clinical Management
Monday, Aug 26th
3:15 PM – 4:00 PM East Coast USA Time
78 - EARLY USE OF ADJUNCTIVE THERAPY TO REDUCE CORONARY ARTERY DAMAGE FROM KAWASAKI DISEASE IN HIGH-RISK INFANTS LESS THAN 6 MONTHS OF AGE: A TWO-CENTER EXPERIENCE
82 - PREDICTING CORONARY ARTERY ABNORMALITIES DEVELOPMENT USING CORONARY Z SCORE AND CLINICAL PARAMETERS BEFORE THE TREATMENT FOR KAWASAKI DISEASE ¦ A MULTICENTER RETROSPECTIVE STUDY IN WAKAYAMA, JAPAN
106 - HEMODYNAMIC ANALYSIS AND RISK ASSESSMENT OF CORONARY ARTERY ANEURYSMS CAUSED BY KAWASAKI DISEASE USING PATIENT-SPECIFIC COMPUTATIONAL FLUID DYNAMICS
40 - RISK FACTORS FOR CORONARY ARTERY ABNORMALITIES AND RESISTANCE TO IMMUNOGLOBULIN PLUS CICLOSPORIN A THERAPY IN SEVERE KAWASAKI DISEASE: SUBANALYSIS OF THE KAICA TRIAL
Location: St-Laurent
Author: Nobuyuki Kakimoto, MD – Department of Pediatrics, Wakaytama Medical University
Clinical Management
Tuesday, Aug 27th
4:10 PM – 4:30 PM East Coast USA Time
45 - MID-TERM OUTCOMES IN KAWASAKI DISEASE PATIENTS WITH GIANT CORONARY ARTERY ANEURYSM: A SINGLE CENTER EXPERIENCE
81 - BOYS AFFECTED WITH KAWASAKI DISEASE DEVELOP MEDIUM AND LARGE CORONARY ARTERY ANEURYSMS MORE THAN TWICE AS MUCH AS GIRLS
Location: St-Laurent
Author: Laurence Watelle, MD – Department of Pediatrics, Faculty of Medicine and Health Sciences, Centre de recherche du Centre Hospitalier Universitaire de Sherbrooke
Author: KENZA BOUAYED, n/a – Hôpital Mère-Enfant A. HAROUCI, CHU IBN ROCHD, Faculté de Médecine et de Pharmacie, Université Hassan II, Casablanca, Morocco
Clinical Management
Tuesday, Aug 27th
4:10 PM – 4:30 PM East Coast USA Time
94 - FOLLOW-UP OF 112 CHILDREN WITH KAWASAKI DISEASE COMPLICATED WITH GIANT CORONARY ARTERY ANEURYSM
Location: St-Laurent
Author: Zhong-Dong Du, n/a – Deapartment of Cardiology, Beijing Children's Hospital, Capital Medical University; Amcare Clinics and Hospital, Amcare Healthcare System
Clinical Management
Tuesday, Aug 27th
4:10 PM – 4:30 PM East Coast USA Time
105 - SAFETY AND TOLERABILITY OF COVID-19 VACCINATION IN INFANTS WITH A HISTORY OF KAWASAKI DISEASE
109 - VARIATION IN THE PROVISION OF KD CARE IN NORTH AMERICAN CENTERS INCLUDING CHANGES SINCE THE COVID-19 PANDEMIC: THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE (CARRA) SURVEY
133 - FROM KAWASAKI TO MULTI SYSTEM INFLAMMATORY DISEASE : LEVERAGING INSIGHTS IN PEDIATRIC VASCULITIS IN THE CREATION OF AN ALGORITHM TO IMPROVE DIAGNOSIS AND TREATMENT STRATEGIES
135 - ASSOCIATION OF ETHNICITY WITH CLINICAL FEATURES AND CARDIAC OUTCOMES FOR KD VERSUS MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN ASSOCIATED WITH COVID-19: A STUDY OF THE INTERNATIONAL KD REGISTRY
136 - FACTORS ASSOCIATED WITH IMPORTANT CORONARY ARTERY ANEURYSMS FOR KAWASAKI DISEASE VERSUS MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN ASSOCIATED WITH COVID-19: A STUDY OF THE INTERNATIONAL KD REGISTRY
145 - RESPONSE OF MEDIUM AND GIANT CORONARY ARTERY ANEURYSMS TO TREATMENT INTENSIFICATION WITH INFLIXIMAB WITH RESPECT TO IT'S TIME OF ADMINISTRATION AFTER INTRAVENOUS IMMUNOGLOBULIN: RETROSPECTIVE ANALYSIS
156 - PERIPHERAL GANGRENE IN KAWASAKI DISEASE: A CLINICAL CONUNDRUM
Location: St-Laurent
Author: munish arora, n/a – PEDIATRIC ALLERGY AND IMMUNOLOGY,ADVANCED PEDIATRICS CENTRE,POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH, INDIA
Clinical Management
Tuesday, Aug 27th
4:10 PM – 4:30 PM East Coast USA Time
164 - DOES CORONARY LESIONS LESS HAPPEN IN KAWASAKI DISEASE WITH MYOCARDITIS?
187 - RISK FACTORS FOR PERSISTENT CORONARY ARTERY ABNORMALITIES IN ITALIAN CHILDREN WITH KAWASAKI DISEASE
Location: St-Laurent
Author: Marianna Fabi, n/a – Pediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
Clinical Management
Tuesday, Aug 27th
4:10 PM – 4:30 PM East Coast USA Time
188 - RETROSPECTIVE ANALYSIS OF KAWASAKI DISEASE TREATMENT OUTCOMES IN POLAND'S POMERANIAN REGION (1997-2021)
Location: St-Laurent
Author: Agnieszka Herrador Rey, N/A, n/a – Department of Paediatric Cardiology and Congenital Heart Defects, Medical University of Gdansk, Poland
Clinical Management
Tuesday, Aug 27th
4:10 PM – 4:30 PM East Coast USA Time
189 - PHARMACOECONOMICS APPLICATIONS IN OPTIMIZING KAWASAKI DISEASE MANAGEMENT ACROSS ARAB NATIONS: A MULTINATIONAL, MULTI-INSTITUTIONAL ENDEAVOR BY THE KAWASAKI DISEASE ARAB INITIATIVE (KAWARABI)
195 - CLINICAL, BIOLOGICAL AND CARDIAC CHARACTERISTICS OF PEDIATRIC INFLAMMATORY MULTISYTEMIC SYNDROME: A SINGLE CENTER EXPERIENCE
Location: St-Laurent
Author: KENZA BOUAYED, n/a – Hôpital Mère-Enfant A. HAROUCI, CHU IBN ROCHD, Faculté de Médecine et de Pharmacie, Université Hassan II, Casablanca, Morocco
Clinical Management
Tuesday, Aug 27th
4:10 PM – 4:30 PM East Coast USA Time
203 - CHANGING EPIDEMIOLOGY OF KAWASAKI DISEASE: DATA FROM EASTERN INDIA
76 - INCOMPLETE KAWASAKI DISEASE VERSUS NON-SEVERE MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN: DISTINGUISHING FEATURES FROM CONTEMPORANEOUS PATIENTS
80 - IDENTIFICATION OF EPIDEMIOLOGIC FEATURES OF KAWASAKI DISEASE USING BIG DATA ANALYSIS FROM THE NATIONAL DATABASE OF HEALTH INSURANCE CLAIMS AND SPECIFIC HEALTH CHECKUPS IN JAPAN
